Metastatic Neoplasm clinical trials at UC Health
1 in progress, 0 open to eligible people
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
Sorry, in progress, not accepting new patients
The purpose of this study is to determine whether patients treated with margetuximab plus chemotherapy have longer progression free survival and overall survival than patients treated with trastuzumab plus chemotherapy.
at UC Davis UCLA UCSF
Last updated: